Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
988
datasets available to search
ShareScore release 0.9.0
Dataset results
988 results for “platinum”
STRIVE: A Single-arm Phase 2 Study on Treatment of Lung Squamous Cell Carcinoma by Tiragolumab Plus Ivonescimab for Patients Who Progressed on Platinum Doublets and Anti-PD-1/PD-L1
ClinicalTrials.gov study NCT07038915. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer
ClinicalTrials.gov study NCT06545617. IPD Sharing: Not stated. Countries: 0. Publications: 0.
JYP0322 Versus Platinum Based Doublet Chemotherapy in ROS1 Positive Patients Previously Treated With ROS1-TKIs.
ClinicalTrials.gov study NCT07154368. IPD Sharing: NO. Countries: 0. Publications: 0.
Olaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in Japan
ClinicalTrials.gov study NCT03063710. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled,
ClinicalTrials.gov study NCT05891080. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
The Exploratory Study of Electroacupuncture in the Treatment of Peripheral Neuropathy Induced by Platinum Based Chemotherapy Drugs
ClinicalTrials.gov study NCT03048591. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy
ClinicalTrials.gov study NCT00270127. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Fluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced Ovarian Cancer
ClinicalTrials.gov study NCT07382713. IPD Sharing: NO. Countries: 0. Publications: 0.
Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer
ClinicalTrials.gov study NCT03942068. IPD Sharing: NO. Countries: 0. Publications: 0.
Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane
ClinicalTrials.gov study NCT02728622. IPD Sharing: NO. Countries: 0. Publications: 0.
Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carc
ClinicalTrials.gov study NCT00408967. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
ClinicalTrials.gov study NCT01131039. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Niraparib and Selenium for the Treatment of Recurrent BRCA Negative Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT05672095. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer
ClinicalTrials.gov study NCT06867562. IPD Sharing: Not stated. Countries: 0. Publications: 0.
A Study Evaluating the Efficacy and Safety of Adjuvant Platinum-Doublet Chemotherapy, With or Without Atezolizumab, in Patients Who Are ctDNA Positive After Complete Surgical Resection of Stage IB to
ClinicalTrials.gov study NCT04611776. IPD Sharing: YES. Countries: 0. Publications: 0.
Resistance of Ovarian Cancer Cells to Platinum Requires Exogenous Cholesterol, Scavenger Receptor Class B Type 1, and Glutathione Peroxidase 4
GEO Series GSE234404. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
The role of the 3D genome organization on platinum drug induced DNA damage susceptibility
GEO Series GSE267578. Homo sapiens. 15 samples. Type: Other.
Genomic Multivariate Predictors of Response to Adjuvant Chemotherapy in Ovarian Carcinoma: Predicting Platinum Resistance
GEO Series GSE30161. Homo sapiens. 58 samples. Type: Expression profiling by array.
Pt-seq unveils the genomic binding pattern of platinum-based drugs [Target-seq and RNA-seq]
GEO Series GSE289502. Cricetulus griseus. 9 samples. Type: Other.
DUSP5P1 promotes gastric cancer metastasis and platinum drug resistance [RNA-seq]
GEO Series GSE213560. Homo sapiens. 2 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.